The European Medicines Evaluation Agency was established in 1995 in London on behalf of the European Union and regulates the standardization and harmonization in medicine applications for marketing authorization from 1995 on. The European Commission has been the driving force in the anticipation of international cooperation and research for harmonization standards. This volume provides an overview of contributions from academic, regulatory and pharmaceutical world on the current state, proposed methods and strategies for future research.